Related Experiment Videos
[Treatment regimen for children and adolescents with Hodgkin's disease designed to decrease late complications of
W Balwierz1, A Moryl-Bujakowska, T Depowska
1Klinika Hematologii i Onkologii Dzieciecej, Polsko-Amerykanski Instytut Pediatrii Collegium Medicum, Uniwersytet Jagielonski, Wielicka 265, 30-663 Krakow, Poland.
Medycyna Wieku Rozwojowego
|May 11, 2002
Summary
Limited radiotherapy in pediatric Hodgkin
Area of Science:
- Pediatric Oncology
- Hematology
Context:
- Hodgkin's disease (HD) in children and adolescents often involves radiotherapy.
- Previous treatment regimens utilized significant radiotherapy doses.
- This study evaluated a regimen with limited radiotherapy use.
Purpose:
- To assess the efficacy and safety of a modified treatment protocol for pediatric Hodgkin's disease.
- To evaluate a treatment strategy involving limited use of radiotherapy (RT) combined with chemotherapy.
- To determine if reduced RT impacts treatment outcomes in pediatric HD.
Summary:
- 167 children and adolescents with Hodgkin's disease (HD) stages I-IV received B-DOPA and MVPP chemotherapy with limited radiotherapy.
- Chemotherapy alone was used in 13 favorable-prognosis patients; others received 15-46.4 Gy RT.
- Four-year survival rates were high (OS 99%, RFS 93%, EFS 90%) with low relapse rates, suggesting limited RT is effective.
Impact:
- This approach demonstrates comparable efficacy to traditional methods with potentially reduced long-term side effects.
- Preliminary findings suggest limited radiotherapy is a viable option for selected pediatric Hodgkin's disease cases.
- Further follow-up is needed to fully assess the impact on late complications.